This Article Full Text Full Text (PDF) Supplemental Data Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Erotokritou-Mulligan, I. Search for Related Content PubMed PubMed Citation Articles by Erotokritou-Mulligan, I. Related Collections Neuroendocrinology and Pituitary Metabolism

The Effect of Sports Injury on Insulin-Like Growth Factor-I and Type 3 Procollagen: Implications for Detection of Growth Hormone Abuse in Athletes

Endocrinology and Metabolism Unit, Developmental Origins of Health and Disease Division, School of Medicine (I.E.-M., C.M., R.S., B.C., V.W., K.H., P.H.S., R.I.G.H.), University of Southampton, Southampton SO16 6YD, United Kingdom; Institute of Mathematics, Statistics, and Actuarial Science (E.E.B.), University of Kent, Canterbury, Kent CT2 7NZ, United Kingdom; and Department of Forensic Science (C.B., D.C.), Drug Monitoring, Drug Control Centre, King’s College London, London SE5 9RS, United Kingdom

Address all correspondence and requests for reprints to: Dr. Richard I. G. Holt, The Institute of Developmental Sciences (IDS Building), MP887, University of Southampton, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, United Kingdom. E-mail: r.i.g.holt{at}soton.ac.uk.

Context: A method to detect exogenously administered growth hormone (GH) based on the measurement of two GH-dependent markers, IGF-I and type 3 procollagen (P-III-P) has been proposed. Skeletal or soft tissue injury may alter these markers. Elevations in either of these proteins after injury might lead to a false accusation of doping with GH.

Objective: The objective of the study was to assess the effect of musculoskeletal or soft tissue injury on IGF-I and P-III-P concentrations in amateur and elite athletes and assess the effect of injury on the proposed GH detection method.

Design: This was a longitudinal observational study after sporting injury.

Setting: The study was conducted at Southampton General Hospital and British Olympic Medical Centre.

Subjects: Subjects included elite and amateur athletes after an injury.

Intervention: Interventions included measurement of IGF-I and P-III-P and application of the GH-2000 discriminant function score up to 84 d after an injury as well as classification of injury by type and severity.

Outcome Measures: IGF-I and P-III-P concentration and ability to detect GH abuse in athletes without the risk of false accusation because of an injury were measured.

Results: There was no change in IGF-I concentration after an injury. By contrast, P-III-P concentrations rose by 41.1 ± 16.6%, reaching a peak around 14 d after an injury. The rise in P-III-P varied according to injury type and severity. This rise had a trivial effect on the GH-2000 discriminant function score, and no subject reached the threshold needed for a doping offense.

Conclusions: Although there was a rise in P-III-P after injury, this was insufficient to invalidate the GH-2000 detection method based on IGF-I and P-III-P concentrations.

This article has been cited by other articles:

				S. Bhasin, E. J. He, M. Kawakubo, E. T. Schroeder, K. Yarasheski, G. J. Opiteck, A. Reicin, F. Chen, R. Lam, J. A. Tsou, et al. N-Terminal Propeptide of Type III Procollagen as a Biomarker of Anabolic Response to Recombinant Human GH and Testosterone J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4224 - 4233. [Abstract] [Full Text] [PDF]

				L. D. Bowers The International Antidoping System and Why It Works Clin. Chem., August 1, 2009; 55(8): 1456 - 1461. [Full Text] [PDF]